CLC Number:
- R473.2
| [1] 陈小斌. 糖尿病患者肺炎疫苗接种率和影响因素调查分析[J].糖尿病新世界,2014,34(19):69-71.DOI:10.16658/j.cnki.1672-4062.2014.19.002. [2] Wang I K, Lin C L, Chang Y C, et al.Effectiveness of Influenza Vaccination in Elderly Diabetic Patients: A Retrospective Cohort Study[J]. Vaccine,2013,31(4):718-724. [3] 陈勤,董旭卉,周吉雅.对稳定期COPD患者实施医院-社区-家庭协同管理的效果[J].中医药管理杂志,2015,23(13):131-133. DOI:10.16690/j.cnki.1007-9203.2015.13.071. [4] 卞薇,谭明琼,温健琳,等.在线患者社会网络在慢性病患者健康行为促进领域中的应用研究进展[J]. 护理学报,2018,25(3):37-41. DOI:10.16460/j.issn1008-9969.2018.03.037.10. [5] Looijmans-Van D A, Verheij T J, Buskens E, et al. Clinical Effectiveness of First and Repeat Influenza Vaccination in Adult and Elderly Diabetic Patients[J]. Diabetes Care,2006,29(8):1771-1776.DOI:10.2337/dc05-2517. [6] Butler J C, Breiman R F, Campbell J F, et al.Pneumococcal Polysaccharide Vaccine Efficacy. An Evaluation of Current Recommendations[J].JAMA,1993,270(15):1826-1831. [7] 王军毅. 23价肺炎球菌多糖疫苗预防糖尿病病人呼吸道感染的成本效果分析[J]. 海峡药学,2013,25(6):274-275. [8] 曾雪红,刘爱容,陈佩祥. 23价肺炎疫苗和流感疫苗在农村地区糖尿病患者中的应用与评价[J].中国实用医药,2017,12(8):28-31. DOI:10.14163/j.cnki.11-5547/r.2017.08.011. [9] Villarroel M A, Vahratian A. Vaccination Coverage Among Adults with Diagnosed Diabetes:United States,2015[J].NCHS Data Brief,2016(265):1-8. [10] 蒋长征,袁月荣,孙灵英,等.城市社区2型糖尿病患者接种流感疫苗知信行调查[J].预防医学,2017, 29(10):1017-1020.DOI:10.19485/j.cnki.issn1007-0931.2017.10.011. [11] 张玲. 糖尿病患者肺炎疫苗接种率和影响因素调查分析[J]. 糖尿病新世界,2017,20(3):13-14.DOI:10.16658/j.cnki.1672-4062.2017.03.013. [12] Zhang Y Y, Tang X F, Du C H, et al.Comparison of Dual Influenza and Pneumococcal Polysaccharide Vaccination with Influenza Vaccination Alone for Preventing Pneumonia and Reducing Mortality Among the Elderly: A Meta-analysis[J]. Hum Vaccin Immunother,2016,12(12):3056-3064.DOI:10.1080/21645515.2016.1221552. [13] Chang Y C, Chou Y J, Liu J Y, et al.Additive Benefits of Pneumococcal and Influenza Vaccines Among Elderly Persons Aged 75 Years or Older in Taiwan-A Representative Population-based Comparative Study[J]. J Infect,2012,65(3):231-238.DOI:10.1016/j.jinf.2012.04.014. [14] Nichol K L.The Additive Benefits of Influenza and Pneumococcal Vaccinations During Influenza Seasons Among Elderly Persons with Chronic Lung Disease[J]. Vaccine,1999,17(Suppl1):91-93.DOI:10.1016/s0264-410x(99)00114-0. [15] 斯德威. 糖尿病足[M]. 天津:天津科技翻译出版公司,2011. [16] 高敏秀,孙肇玢.教学原理与方法护理上之应用[M].台北:伟华书局有限公司,1997. [17] 宋欢,高明霞,柳韦华. 2型糖尿病患者健康信念与血糖自我监测行为的相关性分析[J].护理学报, 2016,23(18):12-16. DOI:10.16460/j.issn1008-9969.2016.18.012. [18] 袁雪丽,王瑞,付莹,等. 2型糖尿病患者流感疫苗接种知信行及影响因素分析[J]. 中国慢性病预防与控制,2018,26(12):905-909.DOI:10.16386/j.cjpccd.issn.1004-6194.2018.12.006. [19] 崔军,李辉,叶莉霞,等.医务人员接种和推荐接种流感疫苗意愿调查[J].预防医学,2017,29(10):1062-1066.DOI:10.19485/j.cnki.issn1007-0931.2017.10.025. [20] 陈琼,王丽静,谢明萱,等.老年人流感和肺炎链球菌疫苗接种中国专家建议[J].中华老年病研究电子杂志,2018,5(2):1-10.DOI:10.3877/cma.j.issn.2095-8757.2018.02.001. [21] Vellozzi C, Burwen D R, Dobardzic A,et al.Safety of Trivalent Inactivated Influenza Vaccines in Adults: Background for Pandemic Influenza Vaccine Safety Monitoring[J]. Vaccine,2009,27(15):2114-2120. DOI:10.1016/j.vaccine.2009.01.125. [22] 张小平,许二萍,刘艳,等.杭州市城区老年人流感疫苗接种情况及其影响因素分析[J].浙江预防医学,2011,23(9):31-32.DOI:10.19485/j.cnki.issn1007-0931.2011.09.010. [23] 王爱红,易波,申涛,等. 宁波市医务人员流感疫苗接种情况及影响因素分析[J]. 中国公共卫生,2013,29(10):1441-1444. DOI:10.11847/zgggws2013-29-10-11. [24] 陶丽丽,卢明,王晓宁,等. 社区综合干预对糖尿病患者接种流感疫苗的效果评价[J].中国疫苗和免疫,2019,25(1):92-95. |
| [1] | . [J]. Journal of Nursing, 2020, 27(12): 14-17. |
| [2] | ZHAO Di, ZHAO Meng-Lu, WANG Na, FU Ming-Jing, LIANG Feng, ZHANG Wei, WANG Ai-Min. Current Status of Social Isolation of Community-dwelling Elderly People in Qingdao and Its Influencing Factors [J]. Journal of Nursing, 2020, 27(11): 6-10. |
| [3] | MENG Fan-yan, CHEN Xuan, WANG Yan, WU Ying. Effect of Reality-based Functional Gait Training on Gait Characteristics and Fear of Fall in Community-dwelling Elderly Convalescent Stroke Patients [J]. Journal of Nursing, 2018, 25(19): 1-4. |
|